Yükleniyor

Yayın ve Akademik Faaliyet Özeti

21
Makale
33
Atıf
6
Bildiri
İndekslere Göre Yayın Sayıları
5 indeks
29
SCI-E
3
TR Dizin
3
ESCI
1
SSCI
1
SCOPUS
Makale Bilgileri
1
Automated Extraction of Key Entities from Non-English Mammography Reports Using Named Entity Recognition with Prompt Engineering, Bioengineering-Basel, 12(2), 2025 SCI / SCI EXPANDED
Prof. Dr. Zafer Akçali, Öğr.Gör. Hazal Selvi Çubuk, Prof. Dr. Arzu Oğuz, Öğr.Gör. Murat Koçak, Araş.Gör.Dr. Aydan Farzaliyeva
2
3
4
5
6
7
Is Tamoxifen Use a Factor Affecting Continence in Breast Cancer Patients?, Cureus, 11(8), 2020 SCOPUS
Prof. Dr. Arzu Oğuz, Gökşen İnanş İmamoğlu, Tülay Eren, Nuriye Yıldırım, Cengiz Karaçin
8
The impact of lymph node ratio on overall survival in patients with colorectal cancer, Journal of Cancer Research and Therapeutics, 8(0), 2020 SCI / SCI EXPANDED
Prof. Dr. Arzu Oğuz, Gökşen İnanç İmamoğlu, Sanem Çimen, Tülay Eren, Cengiz Karaçin
9
10
11
12
Is Human Kallikrein 11 in Non-small Cell Lung Cancer Treated Chemoradiotherapy Associated with Survival?, Cancer Research and Treatment, 48(1), 2016 SCI / SCI EXPANDED
Prof. Dr. Arzu Oğuz, Mehtap Aykaç Çebicci, Serap Tomruk Sütbeyaz, Sema Sezgin Göksu, Sehriban Hocaoğlu
13
14
Dosetaxel Induced Pericardial Effusion in Two Gastric Cancer Patients, UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi, 26(2), 2016 SCI / SCI EXPANDED
Prof. Dr. Arzu Oğuz, Doğan Yazılıtaş, Dilşen Çolak, İnanç İmamoğlu, Mustafa Altınbaş
15
Extracorporeal Shock Wave Therapy for Breast Cancer?Related Lymphedema: A Pilot Study, ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 97(9), 2016 SCI / SCI EXPANDED
Prof. Dr. Arzu Oğuz, Mehtap Aykaç Çebicci, Serap Tomruk Sütbeyaz, Sema Sezgin Göksu, Sehriban Hocaoğlu
16
17
Hepatitis B and C Seroprevalence in Solid Tumors - Necessity for Screening During Chemotherapy, Asian Pacific Journal of Cancer Prevention, 15(3), 2014 SCI / SCI EXPANDED
Prof. Dr. Arzu Oğuz, Fatma Aykaş, Dilek Ünal, Samet Karahan, Emine Uslu
18
Efficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients., JOURNAL OF CLINICAL ONCOLOGY, 32(0), 2014 SCI / SCI EXPANDED
Doğan Uncu, İbrahim Varoğlu, Ülkü Yalçıntaş, Mehmet Küçüköner, Mehmet Artaç
19
20
Is human kallikrein-11 in gastric cancer treated with surgery and adjuvant chemoradiotherapy associated with survival?, PATHOLOGY RESEARCH AND PRACTICE, 209(12), 2013 SSCI
Prof. Dr. Arzu Oğuz, Dilek Ünal, Arzu Taşdemir, Cellalettin Eroğlu, Yasemin Cihan
21
1
Recurrence of hepatocellular carcinoma after liver transplantation: A single-center experience
30th International Congress of The Transplantation-Society (TTS) · 22.09.2024
Araş.Gör.Dr. Aydan Farzaliyeva, Araş.Gör.Dr. Mehmet Nezir Ramazanoğlu, Araş.Gör.Dr. Efe Hasdemir, Doç. Dr. Emre Karakaya, Prof. Dr. Arzu Oğuz
2
Posttransplant malignancies in adult transplant patients: A single center experience
30th International Congress of The Transplantation-Society (TTS) · 22.09.2024
Araş.Gör.Dr. Mehmet Nezir Ramazanoğlu, Araş.Gör.Dr. Aydan Farzaliyeva, Araş.Gör.Dr. Efe Hasdemir, Doç. Dr. Emre Karakaya, Doç. Dr. Samed Rahatlı
3
Automated Extraction of Key Entities from Thorax CT Reports Using NER with Prompt Engineering
2024 World Conference on Lung Cancer · 08.09.2024
Prof. Dr. Zafer Akçali, Araş.Gör.Dr. Aydan Farzaliyeva, Araş.Gör.Dr. Fatih Güven, Araş.Gör.Dr. Mehmet Nezir Ramazanoğlu, Uzm. Dr. Efe Hasdemir
4
Meme Kanseriyle Birlikte Görülen Tiroid Kanserinin Osteoporoz Gelişimi İle İlişkisi
45. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 2024 · 19.04.2024
Araş.Gör.Dr. Ece Gül Köse Hamidi, Arş.Gör.Dr.Enes Arslanoğlu, Araş.Gör.Dr. Deniz Türküm Atikcan Şimşek, Prof. Dr. Özlem Turhan İyidir, Prof. Dr. Asli Nar
5
Combined versus sequential antracycline and taxane adjuvant regimens in triple negative breast cancer patients
ASCO · 12.05.2016
Gül Sema Keskin, Prof. Dr. Arzu Oğuz, Prof. Dr. Zafer Akçali, Prof. Dr. Özden Altundağ
6
Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes.
american society of clinical oncology (ASCO) · 30.05.2014
Taner Babacan, Prof. Dr. Arzu Oğuz, Prof. Dr. Özden Altundağ
↑